Medicine & TechnologyResearchers found that the anticoagulant heparin could help treat COVID-19 patients as it improves symptoms and increase oxygen levels in the lungs by about 70%.
Researchers part of a global collaboration discovered the benefits of using full-dose blood thinners such as heparin reduces the need for organ support like mechanical ventilators and increases the chances of hospital discharge. But the same was not seen in critically ill patients.
A new study reveals that heparin, a common blood thinner, could play an important role in controlling COVID-19. Scientists are optimistic as the same approach has been used in other viruses such as dengue and Zika.